De novo TP53 germline activating mutations in two patients with the phenotype mimicking Diamond-Blackfan anemia.
Daria V FedorovaGalina OvsyannikovaMaria KurnikovaAnna PavlovaTatiana KonyukhovaAlexey PshonkinNataliya S SmetaninaPublished in: Pediatric blood & cancer (2022)
Diamond-Blackfan anemia (DBA) is an inherited bone marrow failure syndrome, associated with mutations in ribosomal protein (RP) genes. Growing data on mutations in non-RP genes in patients with DBA-like phenotype became available over recent years. We describe two patients with the phenotype of DBA (onset of macrocytic anemia within the first year of life, paucity of erythroid precursors in bone marrow) and germline de novo variants in the TP53 gene. Both patients became transfusion independent, probably due to L-leucine therapy. The possible role of TP53 variants should be considered in patients with DBA-like phenotype and no mutations in RP genes.
Keyphrases
- bone marrow
- chronic kidney disease
- end stage renal disease
- genome wide
- genome wide identification
- copy number
- iron deficiency
- mesenchymal stem cells
- newly diagnosed
- dna repair
- bioinformatics analysis
- genome wide analysis
- dna methylation
- cardiac surgery
- peritoneal dialysis
- signaling pathway
- electronic health record
- gene expression
- stem cells
- case report
- patient reported outcomes
- dna damage
- artificial intelligence
- protein protein
- smoking cessation
- replacement therapy